ANAPTYSBIO, INC·4

Jun 17, 6:30 PM ET

Schmid John P. 4

4 · ANAPTYSBIO, INC · Filed Jun 17, 2025

Insider Transaction Report

Form 4
Period: 2025-06-15
Transactions
  • Exercise/Conversion

    Common Stock

    2025-06-15+6,03052,267 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-06-156,0300 total
    Common Stock (6,030 underlying)
Holdings
  • Common Stock

    (indirect: By ESOP)
    11,068
Footnotes (3)
  • [F1]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]The reported shares are held by the Plan of which the Reporting Person is a trustee of the Plan. The Reporting Person has less than 1% of a pecuniary interest in the Plan and disclaims beneficial ownership of these shares to the amount in excess of such Report Person's pecuniary interest.
  • [F3]The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    form4-06172025_100656.xmlPrimary